Dr. Oliver von Stein
Dr. von Stein, the founder of InDex Pharmaceuticals, brings a wealth of expertise in the field of biotechnology with more than two decades of experience in driving scientific research and clinical development of nucleic-based drugs. He successfully oversaw the market success and out-licensing of several nucleic-based drugs and diagnostics.
Prior to joining Berlin Cures, he held various leadership positions at AstraZeneca, OWKIN and other pharma companies, and served as COO at Silence Therapeutics. He completed his PhD in Molecular Biology at the Karlsruhe Institute of Technology.
